| Primary |
| Product Used For Unknown Indication |
42.2% |
| Gastrointestinal Disorder |
11.5% |
| Gastrooesophageal Reflux Disease |
9.8% |
| Drug Use For Unknown Indication |
7.3% |
| Dyspepsia |
6.1% |
| Nausea |
6.1% |
| Abdominal Distension |
4.1% |
| Vomiting |
3.2% |
| Impaired Gastric Emptying |
2.8% |
| Gastric Disorder |
1.1% |
| Abdominal Pain Upper |
0.9% |
| Prophylaxis Of Nausea And Vomiting |
0.8% |
| Pain |
0.7% |
| Suppressed Lactation |
0.6% |
| Diabetic Gastroparesis |
0.6% |
| Gastrointestinal Motility Disorder |
0.5% |
| Hepatitis C |
0.5% |
| Migraine |
0.5% |
| Drug Exposure During Pregnancy |
0.4% |
| Hiatus Hernia |
0.4% |
|
| Tardive Dyskinesia |
28.0% |
| Incorrect Drug Administration Duration |
20.4% |
| Dyskinesia |
10.2% |
| Extrapyramidal Disorder |
9.6% |
| Tremor |
7.4% |
| Adverse Event |
5.7% |
| Movement Disorder |
4.8% |
| Dystonia |
2.0% |
| Pain |
1.8% |
| Economic Problem |
1.3% |
| Vomiting |
1.2% |
| Suicidal Ideation |
1.1% |
| Unevaluable Event |
1.1% |
| Parkinson's Disease |
0.9% |
| Weight Decreased |
0.9% |
| White Blood Cell Count Increased |
0.9% |
| Activities Of Daily Living Impaired |
0.8% |
| Emotional Disorder |
0.8% |
| Injury |
0.8% |
| Nervous System Disorder |
0.7% |
|
| Secondary |
| Product Used For Unknown Indication |
69.3% |
| Dyspepsia |
10.8% |
| Abdominal Distension |
10.2% |
| Impaired Gastric Emptying |
2.6% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Hypertension |
1.0% |
| Nausea |
1.0% |
| Gastrointestinal Disorder |
0.7% |
| Vomiting |
0.5% |
| Drug Use For Unknown Indication |
0.4% |
| Depression |
0.3% |
| Convulsion |
0.3% |
| Cardiac Disorder |
0.3% |
| Abdominal Pain |
0.2% |
| Diabetes Mellitus |
0.2% |
| Pain |
0.2% |
| Fibromyalgia |
0.2% |
| Diabetic Gastroparesis |
0.2% |
| Migraine |
0.2% |
| Arthralgia |
0.2% |
|
| Tardive Dyskinesia |
47.9% |
| Extrapyramidal Disorder |
24.1% |
| Dystonia |
16.8% |
| Dyskinesia |
1.6% |
| Unevaluable Event |
1.5% |
| Tremor |
1.4% |
| Akathisia |
1.3% |
| Drug Hypersensitivity |
0.8% |
| Visual Impairment |
0.7% |
| Incorrect Drug Administration Duration |
0.6% |
| Drug Interaction |
0.5% |
| Restless Legs Syndrome |
0.5% |
| Vomiting |
0.4% |
| Depression Suicidal |
0.3% |
| Movement Disorder |
0.3% |
| Nervous System Disorder |
0.3% |
| Asthenia |
0.2% |
| Condition Aggravated |
0.2% |
| Neuropathy Peripheral |
0.2% |
| Weight Decreased |
0.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.1% |
| Drug Use For Unknown Indication |
26.2% |
| Pain |
6.1% |
| Nausea |
5.3% |
| Gastrooesophageal Reflux Disease |
4.1% |
| Hypertension |
3.3% |
| Depression |
3.3% |
| Anxiety |
2.7% |
| Multiple Myeloma |
2.6% |
| Diabetes Mellitus |
2.0% |
| Constipation |
1.9% |
| Rheumatoid Arthritis |
1.6% |
| Vomiting |
1.5% |
| Asthma |
1.4% |
| Nuclear Magnetic Resonance Imaging |
1.4% |
| Abdominal Pain |
1.4% |
| Breast Cancer |
1.4% |
| Crohn's Disease |
1.2% |
| Insomnia |
1.2% |
| Prophylaxis |
1.2% |
|
| Vomiting |
26.1% |
| Weight Decreased |
11.3% |
| Weight Increased |
5.8% |
| Urinary Tract Infection |
5.6% |
| Nausea |
5.2% |
| Pain |
4.5% |
| Death |
4.0% |
| Pneumonia |
3.9% |
| Pulmonary Embolism |
3.8% |
| Pyrexia |
3.4% |
| White Blood Cell Count Decreased |
3.2% |
| Vision Blurred |
3.1% |
| Type 2 Diabetes Mellitus |
3.1% |
| Sepsis |
2.8% |
| Renal Failure Acute |
2.7% |
| Thrombocytopenia |
2.7% |
| Respiratory Failure |
2.4% |
| Wheezing |
2.1% |
| Dyspnoea |
2.1% |
| Renal Failure |
2.1% |
|
| Interacting |
| Product Used For Unknown Indication |
19.8% |
| Hypertension |
17.4% |
| Convulsion |
9.3% |
| Drug Use For Unknown Indication |
8.1% |
| Adenocarcinoma Pancreas |
7.0% |
| Blood Pressure Abnormal |
5.8% |
| Ingrowing Nail |
5.8% |
| Flushing |
3.5% |
| Heart Rate Abnormal |
3.5% |
| Pain |
3.5% |
| Renal Disorder |
3.5% |
| Ankylosing Spondylitis |
2.3% |
| Chronic Hepatitis C |
2.3% |
| Vomiting |
2.3% |
| Dyspepsia |
1.2% |
| Gastric Disorder |
1.2% |
| Insomnia |
1.2% |
| Migraine |
1.2% |
| Smoking Cessation Therapy |
1.2% |
|
| Vomiting |
21.4% |
| Upper Gastrointestinal Haemorrhage |
14.3% |
| Dizziness |
7.1% |
| Drug Interaction |
7.1% |
| Headache |
7.1% |
| Hypertension |
7.1% |
| Nausea |
7.1% |
| Palpitations |
7.1% |
| Somnambulism |
7.1% |
| Suicidal Ideation |
7.1% |
| Tremor |
7.1% |
|
